By Greg Rubin, CanTest chair The Cytosponge test could help diagnosis of Barrett’s oesophagus in people who are on medication for long term heartburn. A clinical trial led by Prof Rebecca Fitzgerald in Cambridge was published last Friday in The Lancet. Here, CanTest Chair Prof Greg Rubin, who contributed primary care expertise to the trial, explains more about the […]
Imaging activity possibly signalling missed diagnostic opportunities in bladder and kidney cancer: a longitudinal data-linkage study using primary care electronic health records
Blog by Dr Yin Zhou, Clinical Research Fellow, Cancer Group Patterns of events before the diagnosis of cancer may reveal ‘signals’ for missed diagnostic opportunities for patients. Earlier research, including from our CanTest collaborators in Denmark, has shown that increase in background rate of consultations, prescriptions and laboratory test use occur long before cancer diagnosis. […]
COVID-19 research in progress at the Primary Care Unit
During the COVID-19 pandemic, our members are developing research to address COVID-19 related challenges. New projects are described in summary here. Further details will be published as soon as possible. Meanwhile our staff have taken on extended clinical roles. See this post for details. New COVID-19-related research at the Unit 1. Using linked primary care […]
Does one electronic clinical decision support tool fit all clinical settings?
By Stephanie Archer Multi-factorial cancer risk prediction algorithms, such as the Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA), are being used to identify people at higher risk of cancer. CanRisk (www.canrisk.org) is a new web tool that allows healthcare professionals to apply BOADICEA in clinical settings. The MRC have published […]
Further evaluation is required for smartphone-aided diagnosis of skin cancer
Blog by Dr Fiona Walter, head of Cancer Group at the Primary Care Unit and co-director of the international CanTest collaborative Skin cancer is one of the most common cancers in the world, and the incidence is increasing. Could skin cancer detection be transformed by innovative technologies such as digital medicine and artificial intelligence, offering […]
Ruth Etzioni visits PCU Cancer Group
In late January Professor Ruth Etzioni (Affiliate Professor of Biostatistics and Health Services, University of Washington, US and Member of Biostatistics Programme, Fred Hutchison Cancer Research Centre, USA) visited the UK. On the 27th she gave a very well-received keynote address at the Early Detection Programme 5th Annual Symposium in Cambridge, titled From data to […]
- 1
- 2
- 3
- …
- 7
- Next Page »